Placement Completed
Island Pharmaceuticals placement
A$9m raised
Announced 4 Feb 2026 · ASX: ILA · A$0.35 cash per share · -10% premium
Advisers
Island Pharmaceuticals
Issuer
Not disclosed
Lead managers
- Lead manager
- Bookrunner
- Issuer
- Island Pharmaceuticals
- Completed
- 16 Feb 2026
- Sector
- Biotech and pharmaceuticals
Similar deals
- Cann Group placement Oct 2025 · A$9m · Biotech and pharmaceuticals
- INOVIQ placement Oct 2025 · A$9.5m · Biotech and pharmaceuticals
- Chimeric Therapeutics placement Dec 2025 · A$8.4m · Biotech and pharmaceuticals
- Nyrada placement Aug 2025 · A$8.3m · Biotech and pharmaceuticals
- Invex Therapeutics placement Oct 2026 · A$10m · Biotech and pharmaceuticals
Sources
- 4 Feb 2026 $9m placement to advance US biodefence opportunity ASX
- 16 Feb 2026 Application for quotation of securities - ILA ASX